KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Treasury Shares (2016 - 2025)

Historic Treasury Shares for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $1.1 billion.

  • West Pharmaceutical Services' Treasury Shares rose 521.24% to $1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 billion, marking a year-over-year increase of 521.24%. This contributed to the annual value of $1.1 billion for FY2025, which is 521.24% up from last year.
  • As of Q4 2025, West Pharmaceutical Services' Treasury Shares stood at $3.3 million, which was up 1000.0% from $3.4 million recorded in Q3 2025.
  • West Pharmaceutical Services' 5-year Treasury Shares high stood at $3.5 million for Q1 2025, and its period low was $563334.0 during Q3 2022.
  • For the 5-year period, West Pharmaceutical Services' Treasury Shares averaged around $1.8 million, with its median value being $1.3 million (2021).
  • In the last 5 years, West Pharmaceutical Services' Treasury Shares surged by 12351.03% in 2024 and then surged by 521.24% in 2025.
  • West Pharmaceutical Services' Treasury Shares (Quarter) stood at $229.5 million in 2021, then surged by 61.61% to $370.9 million in 2022, then surged by 71.91% to $637.6 million in 2023, then surged by 65.79% to $1.1 billion in 2024, then increased by 5.21% to $1.1 billion in 2025.
  • Its last three reported values are $1.1 billion in Q4 2025, $1.1 billion for Q3 2025, and $1.1 billion during Q2 2025.